Search Results - "CARBONNEAU, DIANE"

Effect of Vupanorsen on Non–High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70 by Bergmark, Brian A., Marston, Nicholas A., Bramson, Candace R., Curto, Madelyn, Ramos, Vesper, Jevne, Alexandra, Kuder, Julia F., Park, Jeong-Gun, Murphy, Sabina A., Verma, Subodh, Wojakowski, Wojtek, Terra, Steven G., Sabatine, Marc S., Wiviott, Stephen D.

“…Genetic loss-of-function variants in are associated with lower levels of plasma lipids. Vupanorsen is a hepatically targeted antisense oligonucleotide that…”
Get full text

Efficacy and safety of an intra-articular placental tissue particulate (MOTYS/PTP-001) in symptomatic knee osteoarthritis over 26 weeks: A placebo-controlled, double-blind randomized clinical trial by Bihlet, Asger R., Pavesio, Alessandra, Kottke, Mary Kathryn, Miller, Claire Prener, Poudel, Pratiksha, Alexandersen, Peter, Rovsing, Helene, Carbonneau, Diane, Hunter, David

Get full text

065 - Efficacy and safety of an intra-articular placental tissue particulate (MOTYS/PTP-001) in symptomatic knee osteoarthritis over 26 weeks: A placebo-controlled, double-blind randomized clinical trial by Bihlet, Asger R., Pavesio, Alessandra, Kottke, Mary Kathryn, Miller, Claire Prener, Poudel, Pratiksha, Alexandersen, Peter, Rovsing, Helene, Carbonneau, Diane, Hunter, David

Get full text

Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI by Kraft, Colleen S., Sims, Matthew, Silverman, Michael, Louie, Thomas J., Feuerstadt, Paul, Huang, Edward S., Khanna, Sahil, Berenson, Charles S., Wang, Elaine E. L., Cohen, Stuart H., Korman, Louis, Lee, Christine, Kelly, Colleen R., Odio, Alberto, Cook, Paul P., Lashner, Bret, Ramesh, Mayur, Kumar, Princy, De, Ananya, Memisoglu, Asli, Lombardi, David A., Hasson, Brooke R., McGovern, Barbara H., von Moltke, Lisa, Pardi, Darrell S.

“…Introduction Recurrent Clostridioides difficile infection (rCDI) often occurs after standard-of-care antibiotics. VOWST oral spores (VOS, previously SER-109),…”
Get full text

Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI by Kraft, Colleen S., Sims, Matthew, Silverman, Michael, Louie, Thomas J., Feuerstadt, Paul, Huang, Edward S., Khanna, Sahil, Berenson, Charles S., Wang, Elaine E. L., Cohen, Stuart H., Korman, Louis, Lee, Christine, Kelly, Colleen R., Odio, Alberto, Cook, Paul P., Lashner, Bret, Ramesh, Mayur, Kumar, Princy, De, Ananya, Memisoglu, Asli, Lombardi, David A., Hasson, Brooke R., McGovern, Barbara H., von Moltke, Lisa, Pardi, Darrell S.

Get full text

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae Among At-Risk Women, Young Sex Workers, and Street Youth Attending Community Organizations in Quebec City, Canada by POULIN, CÉLINE, ALARY, MICHEL, BERNIER, FRANCE, CARBONNEAU, DIANE, BOILY, MARIE-CLAUDE, JOLY, JEAN R.

“…Background: Despite a relatively recent decline in the global incidence of Chlamydia trachomatis and Neisseria gonorrhoeae it seems that some segments of the…”
Get full text